GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

If you’d like to also donate to nonprofits fighting for Social Security, make sure they’re legit and effective, writes ...

Long before any campaign gets started, the one-payer idea is drawing criticism from Colorado groups representing insurers and ...

Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...

CMS administrator Dr. Mehmet Oz announces Trump administration plans to invest over $200 billion in Medicaid following passage of One Big Beautiful Bill.

The groups that pushed for Planned Parenthood to lose Medicaid reimbursement remain confident that a federal judge's ruling ...

By Bill Graham Just a few weeks ago, WakeMed in Raleigh reported ( a surge in heat-related emergency cases, including three children. They weren’t alone. Hospitals across North Carolina have been ...

Eli Lilly, Novo Nordisk Shares Rally As Trump Administration Reportedly Plans To Experiment Including Weight-loss Drugs Under ...

Eagles running back Saquon Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trumps ...

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...